We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-17.68%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$11.5B
AUM Growth
-$2.94B
Cap. Flow
-$38M
Cap. Flow %
-0.33%
Top 10 Hldgs %
32.02%
Holding
373
New
14
Increased
136
Reduced
156
Closed
44

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$161M
2
VZ icon
Verizon
VZ
+$114M
3
ABBV icon
AbbVie
ABBV
+$106M
4
PNC icon
PNC Financial Services
PNC
+$54.5M
5
AVGO icon
Broadcom
AVGO
+$50.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$121M
2
SPG icon
Simon Property Group
SPG
+$93.1M
3
XOM icon
ExxonMobil
XOM
+$71.5M
4
DRI icon
Darden Restaurants
DRI
+$60.2M
5
SYY icon
Sysco
SYY
+$58.6M

Sector Composition

Rank Sector Weight
1 Technology 19.5%
2 Healthcare 15.25%
3 Financials 13.5%
4 Consumer Staples 10.61%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCI icon
176
Donaldson
DCI
$11.4B
$2.79M 0.02%
72,275
-2,908
-4% -$142K
BWXT icon
177
BWX Technologies
BWXT
$15.6B
$2.79M 0.02%
57,172
+999
+2% +$59.4K
EGOV
178
DELISTED
NIC Inc
EGOV
$2.78M 0.02%
120,950
-8,150
-6% -$166K
JNPR
179
DELISTED
Juniper Networks
JNPR
$2.75M 0.02%
143,922
+3,701
+3% +$83.1K
TMO icon
180
Thermo Fisher Scientific
TMO
$220B
$2.75M 0.02%
9,709
+1,444
+17% +$455K
DEO icon
181
Diageo
DEO
$53.6B
$2.7M 0.02%
21,206
-438
-2% -$65.7K
KR icon
182
Kroger
KR
$34.8B
$2.63M 0.02%
87,316
-8,000
-8% -$235K
WST icon
183
West Pharmaceutical
WST
$24.9B
$2.61M 0.02%
17,143
-615
-3% -$94.7K
WPC icon
184
W.P. Carey
WPC
$16.4B
$2.58M 0.02%
45,272
-4,596
-9% -$349K
IEFA icon
185
iShares Core MSCI EAFE ETF
IEFA
$196B
$2.55M 0.02%
51,155
+5,982
+13% +$356K
STAG icon
186
STAG Industrial
STAG
$7.19B
$2.52M 0.02%
111,773
+150
+0.1% +$4.36K
ATR icon
187
AptarGroup
ATR
$8.61B
$2.46M 0.02%
24,667
-610
-2% -$66.1K
STE icon
188
Steris
STE
$23.1B
$2.45M 0.02%
17,486
-5,303
-23% -$793K
DUK icon
189
Duke Energy
DUK
$97.3B
$2.45M 0.02%
30,241
-224
-0.7% -$20.6K
NNN icon
190
NNN REIT
NNN
$8.99B
$2.35M 0.02%
72,955
+12,664
+21% +$636K
MSM icon
191
MSC Industrial Direct
MSM
$6.86B
$2.27M 0.02%
41,202
-8,912
-18% -$587K
AMZN icon
192
Amazon
AMZN
$2.96T
$2.25M 0.02%
23,100
+240
+1% +$23.2K
PRGS icon
193
Progress Software
PRGS
$1.76B
$2.23M 0.02%
69,856
+6,927
+11% +$279K
FITB
194
Fifth Third Bancorp
FITB
$51.8B
$2.23M 0.02%
150,437
-16,147
-10% -$403K
RBA icon
195
RB Global
RBA
$17.5B
$2.23M 0.02%
65,260
+861
+1% +$34.4K
STZ icon
196
Constellation Brands
STZ
$23.2B
$2.19M 0.02%
15,308
-106,531
-87% -$18.8M
HRC
197
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.18M 0.02%
21,633
-2,837
-12% -$294K
CPK icon
198
Chesapeake Utilities
CPK
$3.21B
$2.13M 0.02%
24,853
+1,051
+4% +$97.6K
EFA icon
199
iShares MSCI EAFE ETF
EFA
$80.2B
$2.07M 0.02%
38,697
-2,189
-5% -$139K
T icon
200
AT&T
T
$163B
$2.04M 0.02%
92,442
+7,382
+9% +$202K

Similar funds

Bahl & Gaynor's Q1 2020 Portfolio in Review

As of Q1 2020, Bahl & Gaynor held 373 positions worth $11.5B, down 20% from $14.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q1 2020 filing shows 14 new, 136 increased, 156 reduced and 44 closed positions. Its largest new stake was M.D.C. Holdings, Inc.: 211,717 shares worth $4.55M. The largest sale was Microsoft, an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q1 2020 buy was M.D.C. Holdings, Inc.: 211,717 shares worth $4.55M.
  • Bahl & Gaynor added most to Merck in Q1 2020, an estimated $161M increase.
  • Bahl & Gaynor's biggest Q1 2020 reduction was Microsoft, cutting an estimated $121M.
  • Bahl & Gaynor fully exited Cinemark Holdings in Q1 2020, selling an estimated $6.07M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $11.5B portfolio in Q1 2020.
  • Bahl & Gaynor opened 14 new positions and closed 44 in Q1 2020.
  • Bahl & Gaynor's portfolio value fell 20% quarter-over-quarter to $11.5B.

Based on Bahl & Gaynor's 13F filing for Q1 2020, filed 15 May 2020.